Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C18H25Cl3O2 |
| Molecular Weight | 379.749 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
OC(=O)C(Cl)(Cl)CCCCCCCCCCC1=CC=C(Cl)C=C1
InChI
InChIKey=GPCJDSXBRMKASP-UHFFFAOYSA-N
InChI=1S/C18H25Cl3O2/c19-16-12-10-15(11-13-16)9-7-5-3-1-2-4-6-8-14-18(20,21)17(22)23/h10-13H,1-9,14H2,(H,22,23)
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| BM 17.0744: a structurally new antidiabetic compound with insulin-sensitizing and lipid-lowering activity. | 1999 Jan |
|
| Peroxisome proliferator-activated receptor-alpha ligands inhibit cardiac lipoprotein lipase activity. | 2001 Aug |
|
| The effects of K-111, a new insulin-sensitizer, on metabolic syndrome in obese prediabetic rhesus monkeys. | 2003 Oct |
|
| Human adipocyte fatty acid-binding protein (aP2) gene promoter-driven reporter assay discriminates nonlipogenic peroxisome proliferator-activated receptor gamma ligands. | 2004 Nov |
|
| Drug evaluation: K-111, an insulin-sensitizing peroxisome proliferator-activated receptor alpha agonist. | 2007 Apr |
Patents
| Name | Type | Language | ||
|---|---|---|---|---|
|
Code | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
221564-97-2
Created by
admin on Sat Dec 16 18:02:22 GMT 2023 , Edited by admin on Sat Dec 16 18:02:22 GMT 2023
|
PRIMARY | |||
|
TM9XQR923G
Created by
admin on Sat Dec 16 18:02:22 GMT 2023 , Edited by admin on Sat Dec 16 18:02:22 GMT 2023
|
PRIMARY | |||
|
DTXSID901286589
Created by
admin on Sat Dec 16 18:02:22 GMT 2023 , Edited by admin on Sat Dec 16 18:02:22 GMT 2023
|
PRIMARY | |||
|
9929731
Created by
admin on Sat Dec 16 18:02:22 GMT 2023 , Edited by admin on Sat Dec 16 18:02:22 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
